Inactive Instrument
Argos Therapeutics Inc Stock Nasdaq
Stocks
US0402212023
Pharmaceuticals
OTC Markets Traded| Market Cap | 318K 278K 261K 238K 447K 30.36M 447K 3.13M 1.21M 15.5M 1.19M 1.17M 49.99M | P/E 2016 |
-2.96x | P/E 2017 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 4.58M 4.01M 3.77M 3.44M 6.45M 438M 6.45M 45.2M 17.44M 224M 17.22M 16.84M 722M | EV / Sales 2016 |
200x | EV / Sales 2017 | 9.19x |
| Free-Float |
88.73% | Yield 2016 * |
-
| Yield 2017 | - |
| 1 day | -4.99% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.99% | -75.88% | - | - | 567K | |
| +0.72% | +3.85% | +34.96% | -2.54% | 80.27B | |
| +5.56% | +26.98% | +587.35% | +82.58% | 72.88B | |
| -0.82% | +2.77% | -10.35% | -29.15% | 61.51B | |
| -0.78% | -1.49% | -11.82% | +28.69% | 47.39B | |
| -0.09% | +3.44% | +4.31% | +167.50% | 46.58B | |
| +2.87% | +4.25% | +60.22% | -12.54% | 33.3B | |
| +1.83% | +4.26% | +49.81% | +118.47% | 25.73B | |
| +0.29% | +9.88% | +10.65% | +165.13% | 22.88B | |
| -1.23% | +0.82% | +59.12% | +100.45% | 15.82B | |
| Average | -0.20% | +6.00% | +87.14% | +68.73% | 45.15B | |
| Weighted average by Cap. | +0.28% | +7.38% | +120.78% | +52.12% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 945K 826K 777K 709K 1.33M 90.38M 1.33M 9.32M 3.6M 46.16M 3.55M 3.47M 149M | 1.9M 1.66M 1.56M 1.42M 2.67M 182M 2.67M 18.72M 7.22M 92.73M 7.13M 6.98M 299M |
| Net income | -53.03M -46.34M -43.55M -39.75M -74.6M -5.07B -74.61M -523M -202M -2.59B -199M -195M -8.35B | -40.58M -35.46M -33.33M -30.41M -57.08M -3.88B -57.09M -400M -154M -1.98B -152M -149M -6.39B |
| Net Debt | -13.11M -11.46M -10.77M -9.83M -18.44M -1.25B -18.44M -129M -49.86M -640M -49.23M -48.15M -2.06B | 4.27M 3.73M 3.5M 3.2M 6M 408M 6M 42.07M 16.23M 208M 16.03M 15.67M 672M |
Employees
-
Sector
Pharmaceuticals
